{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:04:40Z","timestamp":1760187880706},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,8,1]],"date-time":"1998-08-01T00:00:00Z","timestamp":901929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[1998,8]]},"DOI":"10.1006\/gyno.1998.5065","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T21:38:48Z","timestamp":1033940328000},"page":"272-274","source":"Crossref","is-referenced-by-count":37,"title":["Phase 2 Trial of Single Agent Ifosfamide\/Mesna in Patients with Platinum\/Paclitaxel Refractory Ovarian Cancer Who Have Not Previously Been Treated with an Alkylating Agent"],"prefix":"10.1006","volume":"70","author":[{"given":"Maurie","family":"Markman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Hurteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertrude","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kulp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Belinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.1998.5065_GO985065RF1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1056\/NEJM199311183292108","article-title":"Cancer of the ovary","volume":"329","author":"Cannistra","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.1998.5065_GO985065RF2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.1998.5065_GO985065RF3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.1992.10.4.513","article-title":"Responses to \u201csalvage\u201d chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population","volume":"10","author":"Markman","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5065_GO985065RF4","first-page":"163","article-title":"Ifosfamide treatment of advanced ovarian cancer","volume":"63","author":"Yazigi","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.1998.5065_GO985065RF5","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1007\/BF00685420","article-title":"Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results","volume":"26","author":"Willemse","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1006\/gyno.1998.5065_GO985065RF6","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1200\/JCO.1989.7.11.1672","article-title":"Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group study","volume":"7","author":"Sutton","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5065_GO985065RF7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1200\/JCO.1992.10.2.243","article-title":"Ifosfamide and mesna in previously-treated advanced epithelial ovarian cancer: activity in platinum-resistant disease","volume":"10","author":"Markman","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5065_GO985065RF8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/gyno.1995.1012","article-title":"A phase 2 trial of ifosfamide\/mesna as salvage therapy in patients with ovarian cancer refractory to or relapsing after prior platinum-containing chemotherapy","volume":"56","author":"Sorensen","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.1998.5065_GO985065RF9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1991.9.3.389","article-title":"Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin","volume":"9","author":"Markman","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5065_GO985065RF10","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1996.14.5.1545","article-title":"Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125","volume":"14","author":"Rustin","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5065_GO985065RF11","unstructured":"Markman, M, Kennedy, A, Webster, K, Kulp, B, Peterson, G, Belinson, J, Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis, Semin Oncol, 23, 97, 98, 1996"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082589895065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082589895065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T01:56:45Z","timestamp":1557280605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082589895065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["S009082589895065X"],"URL":"https:\/\/doi.org\/10.1006\/gyno.1998.5065","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}